Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Ligand Pharm Cmn (NASDAQ: LGND)

$111.17 USD -$0.02 (-0.02%)
Last Price $111.17
Net Change $-0.02 (-0.02%)
Bid $0
Ask Price $0
Open Price $111.19
Previous Close Price $111.19
High Price $111.9
Low Price $110.45
Number of Trades 782
Volume 145,000
Fifty Two Week High $139.79 (2016-08-01)
Fifty Two Week Low $87.5 (2016-11-04)
Average Daily Volume 272,938
Share Outstanding 20,960 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $1.25 (2017-02-23)
2nd Quarter Earnings $0.62 (2016-11-03)
3nd Quarter Earnings $0.5 (2016-08-04)
4th Quarter Earnings $0.97 (2016-05-04)
PE Ratio $135.6
EPS Growth $2263.64
Recent Earnings $1.25
Annual EPS $0.82
Last Quarter EPS $
Market Capitalization $2.33B
Insider Shareholders % 0.147%
Annual Revenue $0B
No. Shares Outstanding 20,960
Inst. Shareholder % 0%
Annual Net Income $0B
TTM Net Profit Margin $100.88
1-Year Return -8.03%
3-Year Return 75.99%
5-Year Return 722.87%
5-Year Revenue Growth 262.75%
5-Year Earnings Growth -121.15%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 2263.639893%
Dividends per Share $2.5
Stock Split Ratio 1-6
Beta 1.27
Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.

LGND News & Stock Updates